VISIOPHARM A/S — Credit Rating and Financial Key Figures
CVR number: 26186676
Agern Alle 24, 2970 Hørsholm
tel: 88202088
Income statement (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 84.26 | 108.50 | 135.97 | 112.09 | 118.19 |
| Other operating income | 0.59 | 0.03 | 0.07 | ||
| Purchases during the financial year | -20.14 | -41.63 | -51.84 | -25.36 | -28.03 |
| External services | -20.17 | -21.58 | -30.61 | -22.91 | -19.12 |
| Gross profit | 44.55 | 66.86 | 84.16 | 86.81 | 90.15 |
| Employee benefit expenses | -64.73 | -83.74 | -72.62 | -78.39 | -73.42 |
| Total depreciation | -8.92 | -7.76 | -8.74 | -9.59 | -9.99 |
| EBIT | -29.11 | -46.22 | -27.80 | -24.08 | -12.38 |
| Other financial income | 0.04 | 0.58 | 4.48 | 0.61 | 1.04 |
| Other financial expenses | -2.67 | -1.09 | -1.00 | -5.71 | -6.13 |
| Pre-tax profit | -31.75 | -46.73 | -24.33 | -29.17 | -17.46 |
| Income taxes | 5.44 | 5.39 | 3.71 | -1.76 | 0.10 |
| Net earnings | -26.31 | -41.34 | -20.61 | -30.93 | -17.36 |
Assets (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible rights | 4.46 | 5.07 | 7.86 | 8.77 | 8.29 |
| Goodwill | 9.73 | 9.73 | 9.73 | 9.73 | 9.73 |
| Intangible assets total | 14.18 | 14.80 | 17.59 | 18.50 | 18.01 |
| Machinery and equipment | 0.71 | ||||
| Other tangible assets | 0.76 | 1.47 | 0.91 | 0.44 | |
| Tangible assets total | 0.71 | 0.76 | 1.47 | 0.91 | 0.44 |
| Other non-current investments | 13.85 | 13.85 | 14.02 | 15.82 | 15.84 |
| Investments total | 13.85 | 13.85 | 14.02 | 15.82 | 15.84 |
| Non-current other receivables | 0.38 | ||||
| Deferred tax assets | 5.49 | 9.75 | 11.91 | 8.77 | 9.31 |
| Long term receivables total | 5.86 | 9.75 | 11.91 | 8.77 | 9.31 |
| Inventories total | 1.40 | 0.20 | 0.18 | 3.24 | 0.99 |
| Current trade debtors | 23.45 | 30.16 | 17.56 | 19.74 | 18.92 |
| Current owed by particip. interest comp. | 0.75 | ||||
| Prepayments and accrued income | 0.51 | 5.63 | 4.98 | 9.56 | 5.76 |
| Current other receivables | 0.52 | 0.78 | 0.33 | 0.07 | |
| Current deferred tax assets | 2.00 | 3.54 | 3.87 | 3.98 | 1.79 |
| Short term receivables total | 27.23 | 40.12 | 26.75 | 33.27 | 26.55 |
| Cash and bank deposits | 90.95 | 54.09 | 35.68 | 48.49 | 47.28 |
| Cash and cash equivalents | 90.95 | 54.09 | 35.68 | 48.49 | 47.28 |
| Balance sheet total (assets) | 154.19 | 133.56 | 107.60 | 129.00 | 118.42 |
Equity and liabilities (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 1.63 | 1.63 | 1.63 | 1.70 | 1.70 |
| Other reserves | 0.21 | -0.44 | -5.96 | -3.25 | -1.27 |
| Retained earnings | 124.94 | 99.56 | 58.55 | 57.02 | 26.08 |
| Profit of the financial year | -26.31 | -41.34 | -20.61 | -30.93 | -17.36 |
| Shareholders equity total | 100.47 | 59.41 | 33.60 | 24.54 | 9.15 |
| Non-current loans from credit institutions | 1.20 | 14.98 | 33.77 | 28.46 | |
| Non-current leasing loans | 2.41 | 0.91 | 0.67 | 2.15 | 2.03 |
| Non-current accruals and deferred income | 1.88 | ||||
| Non-current other liabilities | 3.17 | 2.13 | 3.69 | 5.88 | 5.75 |
| Non-current liabilities total | 7.46 | 4.23 | 19.34 | 41.79 | 36.24 |
| Current loans from credit institutions | 1.94 | 2.09 | 1.06 | 0.30 | 5.42 |
| Current leasing loans | 1.89 | 1.63 | 1.92 | 2.26 | 2.00 |
| Advances received | 1.73 | 1.55 | 1.06 | 1.22 | 1.44 |
| Current trade creditors | 6.00 | 13.34 | 2.36 | 10.18 | 11.00 |
| Other non-interest bearing current liabilities | 24.02 | 32.03 | 19.24 | 17.93 | 17.71 |
| Accruals and deferred income | 10.69 | 19.29 | 28.71 | 30.78 | 35.46 |
| Current liabilities total | 46.26 | 69.92 | 54.35 | 62.67 | 73.03 |
| Balance sheet total (liabilities) | 154.19 | 133.56 | 107.29 | 129.00 | 118.42 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.